Literature DB >> 12429941

Seek and destroy: SCF ubiquitin ligases in mammalian cell cycle control.

Charles H Spruck1, Heimo M Strohmaier.   

Abstract

The eukaryotic cell cycle consists of a series of sequential phases, the order of which is highly regulated to ensure the faithful transmission of intact genome equivalents to daughter cells. Progression through the cell cycle depends on the activity of cyclin-dependent kinases (Cdks), which drive the transitions between phases by targeting numerous, but largely unknown, substrates for phosphorylation. The activity of Cdks is subject to both positive and negative regulation by their temporal association with cyclins and Cdk inhibitors, respectively. Whereas Cdks are constitutively expressed throughout the cell cycle, the levels of cyclins and Cdk inhibitors are regulated by both transcriptional and post-transcriptional processes. The discovery that many cyclins and Cdk inhibitors are unstable proteins has implicated regulated protein degradation as a critical mechanism in cell cycle control. Proteolysis allows for the rapid removal of cell cycle regulators promoting irreversible transitions between cell cycle phases. The rapid removal of positive regulators prevents them from interfering with regulation of subsequent cell cycle events. In this review, we highlight the recent advances of our understanding of how a recently discovered ubiquitin ligase, designated SCF, contributes to mammalian cell cycle control.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429941

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  15 in total

1.  Protein complexes and functional modules in molecular networks.

Authors:  Victor Spirin; Leonid A Mirny
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-29       Impact factor: 11.205

2.  Brd4 regulation of papillomavirus protein E2 stability.

Authors:  Gang Zheng; Michal-Ruth Schweiger; Gustavo Martinez-Noel; Leon Zheng; Jennifer A Smith; J Wade Harper; Peter M Howley
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

3.  The ubiquitin-proteasome pathway is necessary for maintenance of the postmitotic status of neurons.

Authors:  John F Staropoli; Asa Abeliovich
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Glucose inhibits meiotic DNA replication through SCFGrr1p-dependent destruction of Ime2p kinase.

Authors:  Kedar Purnapatre; Misa Gray; Sarah Piccirillo; Saul M Honigberg
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

5.  A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome/E3 ligase component SKP1A.

Authors:  Tali Fishman-Jacob; Lydia Reznichenko; Moussa B H Youdim; Silvia A Mandel
Journal:  J Biol Chem       Date:  2009-09-11       Impact factor: 5.157

6.  The roles of the cell division cycle-associated gene family in hepatocellular carcinoma.

Authors:  Qiang Tao; Siliang Chen; Jia Liu; Peng Zhao; Lingmin Jiang; Xinyue Tu; Xiang Tang; Zonghao Liu; Abudoukeyimu Yasheng; Kahaer Tuerxun; Yun Zheng
Journal:  J Gastrointest Oncol       Date:  2021-04

7.  The Ubiquitin-Proteasome System and F-box Proteins in Pathogenic Fungi.

Authors:  Tong-Bao Liu; Chaoyang Xue
Journal:  Mycobiology       Date:  2011-12-07       Impact factor: 1.858

8.  Degradation ensures integrity.

Authors:  Anatoliy Li; J Julian Blow
Journal:  Nature       Date:  2003-06-19       Impact factor: 49.962

9.  Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest.

Authors:  Fumihiko Uchida; Katsuhiro Uzawa; Atsushi Kasamatsu; Hiroaki Takatori; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Hiroki Bukawa
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

Review 10.  Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control.

Authors:  Walter Becker
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.